Covalent-103: A Phase 1, Open-Label, Dose-Escalation, and Dose-Expansion Study of Bmf-500, an Oral Covalent FLT3 Inhibitor, in Adults with Acute Leukemia (AL)
- Resource Type
- Article
- Source
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p1546-1546, 1p
- Subject
- Language
- ISSN
- 00064971; 15280020